The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Lacosamide
Lacosamide · LACOSAMIDE 50 mg/1 · Tablet · Oral · Amneal Pharmaceuticals of New York LLC
NDC 53746-0923-05 · 500 TABLET in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.2%chance of a new FDA shortage posting for lacosamide (oral solid) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market · 1 Class I/II recall(s) in 12 months
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- analysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA204857
- TE code
- —
- Approval date
- Mar 17, 2022
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Lacosamide (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Amneal Pharmaceuticals of New York LLC | LACOSAMIDE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals of New York LLC | LACOSAMIDE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals of New York LLC | LACOSAMIDE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals of New York LLC | LACOSAMIDE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Florida Pharmaceutical Products, LLC | LACOSAMIDE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Florida Pharmaceutical Products, LLC | LACOSAMIDE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Florida Pharmaceutical Products, LLC | LACOSAMIDE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Florida Pharmaceutical Products, LLC | LACOSAMIDE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Indoco Remedies Limited | LACOSAMIDE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Indoco Remedies Limited | LACOSAMIDE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Indoco Remedies Limited | LACOSAMIDE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Indoco Remedies Limited | LACOSAMIDE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NorthStar RxLLC | LACOSAMIDE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NorthStar RxLLC | LACOSAMIDE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NorthStar RxLLC | LACOSAMIDE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NorthStar RxLLC | LACOSAMIDE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Tris Pharma Inc | LACOSAMIDE 50 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Tris Pharma Inc | LACOSAMIDE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Tris Pharma Inc | LACOSAMIDE 150 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Tris Pharma Inc | LACOSAMIDE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Lacosamide — NDC 53746-0923-05," retrieved September 3, 2026, https://drugdashboards.com/drug/53746092305.
Free to cite with attribution — see how the data is put together.